Design Therapeutics Inc
NASDAQ:DSGN

Watchlist Manager
Design Therapeutics Inc Logo
Design Therapeutics Inc
NASDAQ:DSGN
Watchlist
Price: 6.5781 USD -12.29% Market Closed
Market Cap: 372.5m USD
Have any thoughts about
Design Therapeutics Inc?
Write Note

Cash Flow Statement

Cash Flow Statement
Design Therapeutics Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Operating Cash Flow
Net Income
(22)
(36)
(43)
(51)
(57)
(63)
(69)
(74)
(72)
(67)
(59)
(51)
(48)
Depreciation & Amortization
0
0
0
0
0
0
0
1
1
1
1
1
1
Stock-Based Compensation
3
5
6
8
9
11
12
13
13
13
13
12
0
Other Non-Cash Items
3
5
7
8
9
10
9
9
8
7
6
6
6
Cash Interest Paid
(0)
0
0
0
0
0
0
0
0
0
0
0
0
Change in Working Capital
3
1
(1)
3
2
2
3
4
3
1
(2)
(7)
(5)
Cash from Operating Activities
(16)
N/A
(29)
-82%
(38)
-28%
(40)
-6%
(45)
-14%
(51)
-13%
(57)
-11%
(60)
-6%
(61)
-1%
(59)
+4%
(54)
+9%
(51)
+5%
(46)
+10%
Investing Cash Flow
Capital Expenditures
(1)
(2)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(0)
(0)
(0)
(0)
Other Items
36
(52)
(75)
(210)
(269)
(220)
(201)
(32)
46
53
54
69
48
Cash from Investing Activities
35
N/A
(54)
N/A
(76)
-42%
(212)
-178%
(270)
-28%
(221)
+18%
(202)
+9%
(33)
+84%
46
N/A
53
+14%
53
+2%
69
+29%
48
-31%
Financing Cash Flow
Net Issuance of Common Stock
334
379
0
1
1
1
1
0
0
1
1
1
1
Net Issuance of Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
Other
0
0
0
(0)
(0)
(0)
0
0
0
0
0
0
0
Cash from Financing Activities
334
N/A
379
+13%
0
-100%
0
-56%
0
+76%
0
-20%
0
-67%
1
+525%
0
-30%
1
+107%
1
+3%
1
+3%
1
-1%
Change in Cash
Net Change in Cash
353
N/A
296
-16%
(113)
N/A
(251)
-122%
(315)
-25%
(272)
+14%
(259)
+5%
(92)
+64%
(15)
+84%
(5)
+64%
1
N/A
18
+3 051%
2
-87%
Free Cash Flow
Free Cash Flow
(17)
N/A
(31)
-78%
(39)
-26%
(41)
-6%
(46)
-12%
(52)
-12%
(58)
-11%
(61)
-5%
(61)
-1%
(59)
+4%
(54)
+8%
(51)
+5%
(46)
+10%

See Also

Discover More